Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rifampicin Susceptible Pulmonary Tuberculosis”

20 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 20 results

Testing effectiveness (Phase 2)Study completedNCT04629378
What this trial is testing

Evaluating the EBA of Meropenem With Amoxicillin/Clavulanate and Pyrazinamide or Bedaquiline in Adults With PTB

Who this might be right for
Tuberculosis
TASK Applied Science 22
Not applicableStudy completedNCT00834353
What this trial is testing

Prospective Study of N-acetyltransferase2 (NAT2) and Cytochrome P4502E1 (CYP2E1) Gene as Susceptible Risk Factors for Antituberculosis (ATT) Induced Hepatitis

Who this might be right for
Pulmonary Tuberculosis
Maulana Azad Medical College
Post-approval studies (Phase 4)Study completedNCT02231229
What this trial is testing

Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation

Who this might be right for
Tuberculosis
Assistance Publique - Hôpitaux de Paris 204
Testing effectiveness (Phase 2)Looking for participantsNCT07073638
What this trial is testing

Phase 2 Trial to Evaluate the Safety and Tolerability and Early Bactericidal Activity of RESP30TB in Tuberculosis

Who this might be right for
Pulmonary Tuberculoses
Thirty Respiratory Limited 24
Testing effectiveness (Phase 2)Temporarily pausedNCT04694586
What this trial is testing

Drug Exposure and Safety of a Shorter Tuberculosis Treatment Based on High-Dose Rifampicin and Pyrazinamide

Who this might be right for
Tuberculosis, Pulmonary
University Hospital, Linkoeping 40
Testing effectiveness (Phase 2)Ended earlyNCT06041919
What this trial is testing

Evaluating the Early Bactericidal Activity, Safety and Tolerability of Nebulised RESP301 in Adults With Tuberculosis

Who this might be right for
Rifampicin Susceptible Pulmonary Tuberculosis
Thirty Respiratory Limited 20
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06205589
What this trial is testing

Therapeutic ID93 + GLA-SE Vaccination in Participants With Rifampicin-Susceptible Pulmonary TB

Who this might be right for
Tuberculosis, Pulmonary
Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections 1,500
Testing effectiveness (Phase 2)Study completedNCT04734652
What this trial is testing

INSTI's For The Management of HIV-associated TB

Who this might be right for
HIV/AIDSTuberculosis, Pulmonary
Centre for the AIDS Programme of Research in South Africa 122
Testing effectiveness (Phase 2)UnknownNCT01994460
What this trial is testing

Linezolid Instead of Ethambutol in Treatment of Drug-susceptible Tuberculosis

Who this might be right for
Pulmonary Tuberculosis Without Resistance to Rifampicin
Seoul National University Hospital 429
Testing effectiveness (Phase 2)Study completedNCT03174184
What this trial is testing

Early Bactericidal Activity of Rifampin + Meropenem + Amoxicillin/Clavulanate in Adults With Pulmonary TB

Who this might be right for
Tuberculosis, Pulmonary
Johns Hopkins University 112
Testing effectiveness (Phase 2)Study completedNCT05473195
What this trial is testing

Trial to Evaluate the EBA, Safety and Tolerability of Eto Alone and in Combination With BVL-GSK098

Who this might be right for
Rifampicin- and Isoniazid-Susceptible Pulmonary Tuberculosis (TB)
TASK Applied Science 105
Testing effectiveness (Phase 2)Study completedNCT05388448
What this trial is testing

EBA, Safety and Tolerability of Sanfetrinem Cilexetil

Who this might be right for
Tuberculosis, Pulmonary
TASK Applied Science 54
Large-scale testing (Phase 3)Looking for participantsNCT04260477
What this trial is testing

Novel Triple-dose Tuberculosis Retreatment Regimen

Who this might be right for
Multidrug-resistant TuberculosisPulmonary TuberculosisTuberculosis+1 more
Institute of Tropical Medicine, Belgium 370
Testing effectiveness (Phase 2)Study completedNCT05896930
What this trial is testing

Study to Evaluate EBA, Safety and Tolerability of Carbapenems in Adults With Pulmonary Tuberculosis

Who this might be right for
Pulmonary Tuberculosis
TASK Applied Science 134
Large-scale testing (Phase 3)Not Yet RecruitingNCT06526039
What this trial is testing

A Short Regimen for Rifampicin-resistant Isoniazid-susceptible TB

Who this might be right for
Tuberculosis, Pulmonary
Taipei Medical University WanFang Hospital 100
Testing effectiveness (Phase 2)Study completedNCT05382312
What this trial is testing

Early Bactericidal Activity, Safety & Tolerability of Oral GSK3036656 in a Dual Combination With Novel and Established Antitubercular Agents, or Standard of Care in Adults With Rifampicin Susceptible Pulmonary Tuberculosis

Who this might be right for
Tuberculosis
GlaxoSmithKline 127
Testing effectiveness (Phase 2)Looking for participantsNCT06748937
What this trial is testing

The Early Effects, Safety, and Acceptability of Oral Alpibectir in Combination With Ethionamide

Who this might be right for
Tuberculosis
TASK Applied Science 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07595042
What this trial is testing

A Trial of Stratified Patient-Centered Treatment Regimens for Active TB (SPECTRA-TB)

Who this might be right for
Tuberculosis
National Institute of Allergy and Infectious Diseases (NIAID) 900
Testing effectiveness (Phase 2)UnknownNCT04768231
What this trial is testing

Rifampicin at High Dose for Difficult-to-Treat Tuberculosis

Who this might be right for
Tuberculosis
Hospital Universitari Vall d'Hebron Research Institute 130
Large-scale testing (Phase 3)UnknownNCT05575518
What this trial is testing

A Pragmatic Trial With Optimized Dose of Rifampicin and Moxifloxacin for the Treatment of Drug Susceptible Pulmonary Tuberculosis

Who this might be right for
TuberculosisHuman Immunodeficiency Virus
Stellah Mpagama 414
Next Page